Executive Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$8.72M Sell
87,675
-15,409
-15% -$1.59M 0.68% 43
2024
Q3
$11.7M Buy
103,084
+37,059
+56% +$4.4M 0.92% 25
2024
Q2
$8.17M Buy
66,025
+2,523
+4% +$325K 1.5% 20
2024
Q1
$8.32M Buy
63,502
+19,288
+44% +$2.38M 0.73% 45
2023
Q4
$4.82M Buy
44,214
+40,135
+984% +$4.17M 0.45% 68
2023
Q3
$420K Sell
4,079
-377
-8% -$40.6K 0.04% 147
2023
Q2
$514K Buy
4,456
+156
+4% +$17.7K 0.05% 132
2023
Q1
$458K Buy
4,300
+124
+3% +$13.4K 0.05% 138
2022
Q4
$463K Buy
4,176
+3,837
+1,132% +$392K 0.06% 136
2022
Q3
$339 Sell
339
-3,503
-91% -$313K 0.05% 138
2022
Q2
$350K Buy
3,842
+244
+7% +$21.6K 0.05% 138
2022
Q1
$295K Buy
3,598
+30
+0.8% +$2.37K 0.03% 164
2021
Q4
$273K Buy
3,568
+99
+3% +$7.88K 0.03% 168
2021
Q3
$260K Sell
3,469
-143
-4% -$10.9K 0.03% 159
2021
Q2
$280K Sell
3,612
-486
-12% -$36.1K 0.03% 161
2021
Q1
$301K Sell
4,098
-56,337
-93% -$4.16M 0.04% 156
2020
Q4
$4.72M Buy
60,435
+6,879
+13% +$526K 0.58% 51
2020
Q3
$4.24M Buy
53,556
+2,079
+4% +$163K 0.59% 46
2020
Q2
$3.8M Sell
51,477
-6,312
-11% -$475K 0.57% 39
2020
Q1
$4.24M Buy
57,789
+117
+0.2% +$9.2K 0.75% 24
2019
Q4
$5M Buy
57,672
+4,510
+8% +$370K 0.68% 40
2019
Q3
$4.27M Buy
53,162
+3,472
+7% +$278K 0.65% 37
2019
Q2
$3.98M Buy
49,690
+6,399
+15% +$490K 0.56% 40
2019
Q1
$3.44M Sell
43,291
-839
-2% -$62.8K 0.61% 38
2018
Q4
$3.22M Buy
+44,130
New +$3.12M 0.57% 33

Other funds holding MRK

Executive Wealth Management's MRK Position: Q4 2024 in Review

Executive Wealth Management reduced its Merck (MRK) stake by 15% in Q4 2024, selling an estimated $1.59M and leaving 87,675 shares worth $8.72M. The position accounts for 0.68% of the portfolio, ranked #43.

Executive Wealth Management first reported a position in MRK in Q4 2018 and has held it in 25 quarters since. The position peaked at $11.7M in Q3 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Executive Wealth Management held 87,675 shares of Merck worth $8.72M as of Q4 2024.
  • Executive Wealth Management sold 15,409 Merck shares in Q4 2024, an estimated $1.59M.
  • Merck made up 0.68% of Executive Wealth Management's portfolio in Q4 2024, its #43 holding.
  • Executive Wealth Management first reported a position in Merck in Q4 2018 and has held it in 25 quarters since.
  • Executive Wealth Management's Merck position peaked at $11.7M in Q3 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Executive Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.